Viewing Study NCT01994668


Ignite Creation Date: 2025-12-24 @ 5:53 PM
Ignite Modification Date: 2025-12-27 @ 7:33 AM
Study NCT ID: NCT01994668
Status: COMPLETED
Last Update Posted: 2014-03-03
First Post: 2013-11-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 1 Study to Characterize the Safety and Pharmacokinetics of Single Intravenous Dose of Lorazepam in Healthy Japanese Adult Subjects
Sponsor: Pfizer
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None lorazepam View
None intravenous View
None pharmacolinetics View
None healthy View
None Japanese View